We thank Dr. Pontiroli, and agree with his commentary (1). Dr. Pontiroli provides an interesting observation regarding change in b-cell function following weight loss by gastric banding in subjects with type 2 diabetes. His data show minimal improvement in insulin release, as assessed by the Dinsulin/Dglucose during an oral glucose tolerance test (OGTT), but a significant improvement in insulin sensitivity by homeostasis model assessment, 18 months after gastric banding (1,2). In our study (3), we observed a significant improvement in both b-cell glucose sensitivity (slope of the insulin response to a change in plasma glucose levels) during an oral glucose challenge, and insulin sensitivity by homeostasis model assessment, after 10% and 30% weight loss by Roux-en-Y gastric bypass (RYGBP). The improvement in insulin secretion after RYGBP and the lack of improvement after gastric banding suggests indeed that gastrointestinal factors, potentially incretins, are important for insulin secretion in response to nutrient ingestion after RYGBP. This is further confirmed by our finding that b-cell glucose sensitivity minimally improves upon intravenous glucose stimulation after 10% or 30% weight loss, in spite of clinical diabetes remission. Comparison between these studies with slightly different modeling, while extremely valuable, does not account for potential differences in weight loss between studies.
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Similar to Pontiroli's and our own data, Kashyap et al. 
